2021
Major ABO Incompatibility Significantly Influences the Survival and Outcomes after Allogeneic Hematopoietic Cell Transplantation in Leukemia - CIBMTR Analysis
Murthy S, Logan B, Bo-Subait S, Beitingjaneh A, Devine S, Farhadfar N, Gowda L, Hashmi S, Lazarus H, Nathan S, Sharma A, Yared J, Stefanski H, Pulsipher M, Hsu J, Switzer G, Panch S, Shaw B. Major ABO Incompatibility Significantly Influences the Survival and Outcomes after Allogeneic Hematopoietic Cell Transplantation in Leukemia - CIBMTR Analysis. Blood 2021, 138: 907. DOI: 10.1182/blood-2021-150635.Peer-Reviewed Original ResearchAcute myeloid leukemiaNon-relapse mortalityBidirectional ABO mismatchMajor ABO mismatchABO mismatchDisease-free survivalPrimary graft failureHematopoietic cell transplantationAllo-HCTAcute lymphoblastic leukemiaOverall survivalABO statusAcute GVHDPlatelet engraftmentGraft failureGraft manipulation techniquesChronic GVHDABO incompatibilityCell transplantationCox proportional hazards regression methodsT-cell depleted graftAllogeneic hematopoietic cell transplantationGraft manipulation strategiesMinor ABO mismatchPost-transplant outcomes
2016
Transfusion support for the oncology patient
Schulz W, Snyder E. Transfusion support for the oncology patient. 2016, 574-580. DOI: 10.1002/9781119013020.ch50.ChaptersOncology patientsTransfusion supportTransfusion-transmitted diseasesSafety of transfusionTA-GVHDTransplant patientsAdverse eventsDonor testingAppropriate therapyABO incompatibilityPatient populationTransfusion therapyOncologic disordersMajor therapyPatientsTransfusion servicesCellular antigensBlood componentsTherapyFrequent exposureTransfusionSpecific assessmentRiskAlloimmunizationImmunomodulation
2015
Case study: Use of A2 and donor red blood cells for anti ABO a titer
Miller M, Bow L. Case study: Use of A2 and donor red blood cells for anti ABO a titer. Human Immunology 2015, 76: 97. DOI: 10.1016/j.humimm.2015.07.141.Peer-Reviewed Original ResearchDonor RBCsIgG titersABO incompatibilityTransplant programsBlood group O recipientsBlood group A antigensWeak antigen expressionABO-incompatible transplantsGroup O recipientsBlood group OYear old maleGroup A antigensBlood group AA1 RBCsABOi transplantsIncompatible transplantsKidney transplantationRecipient serumAbsolute contraindicationKidney transplantRed blood cellsAntibody titersAntigen subtypesO recipientsIgG antibodies
2014
Issues in solid-organ transplantation in children: translational research from bench to bedside
Lipshultz SE, Chandar JJ, Rusconi PG, Fornoni A, Abitbol CL, Burke GW, Zilleruelo GE, Pham SM, Perez EE, Karnik R, Hunter JA, Dauphin DD, Wilkinson JD. Issues in solid-organ transplantation in children: translational research from bench to bedside. Clinics 2014, 69: 55-72. PMID: 24860861, PMCID: PMC3884162, DOI: 10.6061/clinics/2014(sup01)11.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsAntibody-mediated rejectionRenal transplantationCardiac transplantationGraft rejectionAcute antibody-mediated rejectionChronic antibody-mediated rejectionCardiac allograft vasculopathyPanel reactive antibodyPediatric renal transplantationPediatric cardiac transplantationCardiac graft rejectionSolid organ transplantationBiomarkers of inflammationCardiac transplant rejectionRole of biomarkersNew diagnostic approachAllograft vasculopathyHeart transplantationKidney transplantationEndomyocardial biopsyABO incompatibilityTransplant rejectionCardiomyocyte injuryAntibody assaysImmune function
1996
Fetal ascites associated with ABO incompatibility: Case report and review of the literature
Stiller R, Herzlinger R, Siegel S, Whetham J. Fetal ascites associated with ABO incompatibility: Case report and review of the literature. American Journal Of Obstetrics And Gynecology 1996, 175: 1371-1372. PMID: 8942517, DOI: 10.1016/s0002-9378(96)70057-1.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply